- Home
- QCRH vs TXG Comparison
QCRH vs TXG Comparison
Compare QCRH & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QCRH
- TXG
- Stock Information
- Founded
- QCRH 1993
- TXG 2012
- Country
- QCRH United States
- TXG United States
- Employees
- QCRH N/A
- TXG N/A
- Industry
- QCRH Major Banks
- TXG Biotechnology: Laboratory Analytical Instruments
- Sector
- QCRH Finance
- TXG Industrials
- Exchange
- QCRH Nasdaq
- TXG Nasdaq
- Market Cap
- QCRH 1.1B
- TXG 1.0B
- IPO Year
- QCRH 1993
- TXG 2019
- Fundamental
- Price
- QCRH $67.06
- TXG $8.77
- Analyst Decision
- QCRH Buy
- TXG Buy
- Analyst Count
- QCRH 3
- TXG 15
- Target Price
- QCRH $86.67
- TXG $18.85
- AVG Volume (30 Days)
- QCRH 91.1K
- TXG 4.0M
- Earning Date
- QCRH 04-22-2025
- TXG 05-08-2025
- Dividend Yield
- QCRH 0.36%
- TXG N/A
- EPS Growth
- QCRH N/A
- TXG N/A
- EPS
- QCRH 6.65
- TXG N/A
- Revenue
- QCRH $324,275,000.00
- TXG $624,662,000.00
- Revenue This Year
- QCRH N/A
- TXG $0.71
- Revenue Next Year
- QCRH $15.85
- TXG $9.28
- P/E Ratio
- QCRH $10.01
- TXG N/A
- Revenue Growth
- QCRH N/A
- TXG N/A
- 52 Week Low
- QCRH $54.75
- TXG $6.78
- 52 Week High
- QCRH $96.08
- TXG $28.25
- Technical
- Relative Strength Index (RSI)
- QCRH 50.57
- TXG 52.90
- Support Level
- QCRH $64.64
- TXG $7.72
- Resistance Level
- QCRH $67.00
- TXG $8.63
- Average True Range (ATR)
- QCRH 1.82
- TXG 0.52
- MACD
- QCRH 0.48
- TXG 0.15
- Stochastic Oscillator
- QCRH 49.42
- TXG 43.30
About QCRH QCR Holdings Inc.
QCR Holdings Inc is a multi-bank holding company. The bank operates through segments namely Commercial Banking, Wealth Management, and all other segments. The commercial bank segment is geographically divided by markets namely QCBT, CRBT, CSB, and GB. It generates revenue in the form of interest.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).